Murine bone marrow-derived dendritic cells as a potential in vitro model for predictive identification of chemical sensitizers

Toxicology Letters

Volumn 175, Issue 1-3, 2007, Pages 89-101

  Pépin, Elsa ^a   Goutet, Michèle ^a   Ban, Masarin ^a  

^a INSTITUT NATIONAL DE RECHERCHE ET DE SÉCURITÉ   (France)

Author keywords

Contact allergy; Dendritic cells; In vitro sensitization test

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; 1 FLUORO 2,4 DINITROBENZENE; 4 AMINOBENZOIC ACID; ALLERGEN; CINNAMALDEHYDE; DODECYL SULFATE SODIUM; LIPOPOLYSACCHARIDE; NICKEL SULFATE; PHENYLENEDIAMINE; ZINC SULFATE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; FLUORESCENCE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN SENSITIZATION; UPREGULATION;

4-AMINOBENZOIC ACID; ACROLEIN; ALLERGENS; ANIMALS; ANTIGENS, SURFACE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DINITROCHLOROBENZENE; DINITROFLUOROBENZENE; IRRITANTS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; NICKEL; PHENYLENEDIAMINES; SODIUM DODECYL SULFATE; TOXICITY TESTS;

ANIMALIA; MURINAE;

EID: 36248991389     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2007.09.012     Document Type: Article

References (39)

1. Aeby P., Wyss C., Beck H., Griem P., Scheffler H., and Goebel C. Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. J. Invest. Dermatol. 122 (2004) 1154-1164
2. Aiba S., Terunuma A., Manome H., and Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol. 27 (1997) 3031-3038
3. Aiba S., Manome H., Yoshino Y., and Tagami H. In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 101 (2000) 68-75
4. Ashikaga T., Hoya M., Itagaki H., Katsumura Y., and Aiba S. Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicol. In Vitro 16 (2002) 711-716
5. Azam P., Peiffer J.L., Chamousset D., Tissier M.H., Bonnet P.A., Vian L., Fabre I., and Ourlin J.C. The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. Toxicol. Appl. Pharmacol. 212 (2006) 14-23
6. Basketter D.A., Gerberick G.F., and Kimber I. Strategies for identifying false positive responses in predictive skin sensitization tests. Food Chem. Toxicol. 36 (1998) 327-333
7. Boisleve F., Kerdine-Romer S., Rougier-Larzat N., and Pallardy M. Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: role of TNF-alpha and MAPK. J. Invest. Dermatol. 123 (2004) 494-502
8. Buehler E.V. Delayed contact hypersensitivity in the guinea pig. Arch. Dermatol. 91 (1965) 171-177
9. Coutant K.D., de Fraissinette A.B., Cordier A., and Ulrich P. Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol. Sci. 52 (1999) 189-198
10. De Smedt A.C., Van Den Heuvel R.L., Zwi Berneman N., and Schoeters G.E. Modulation of phenotype, cytokine production and stimulatory function of CD34+-derived DC by NiCl(2) and SDS. Toxicol. In Vitro 15 (2001) 319-325
11. De Smedt A.C., Van Den Heuvel R.L., Van Tendeloo V.F., Berneman Z.N., and Schoeters G.E. Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitizers and irritants. Toxicol. Lett. 156 (2005) 377-389
12. Gerberick G.F., Ryan C.A., Kimber I., Dearman R.J., Lea L.J., and Basketter D.A. Local lymph node assay: validation assessment for regulatory purposes. Am. J. Contact Dermat. 11 (2000) 3-18
13. Hulette B.A., Ryan C.A., and Gerberick G.F. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol. Appl. Pharmacol. 182 (2002) 226-233
14. Hulette B.C., Ryan C.A., Gildea L.A., and Gerberick G.F. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. Toxicol. Appl. Pharmacol. 209 (2005) 159-166
15. ICCVAM (Interagency Coordinating Committee on the Validation of Alternative Methods). The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds (1999) NIH Publication No. 99-4494
16. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., and Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
17. Jugde F., Boissier C., Rougier-Larzat N., Corlu A., Chesne C., Semana G., and Heresbach D. Regulation by allergens of chemokine receptor expression on in vitro-generated dendritic cells. Toxicology 212 (2005) 227-238
18. Kimber I., Cumberbatch M., Betts C.J., and Dearman R.J. Dendritic cells and skin sensitisation hazard assessment. Toxicol. In Vitro 18 (2004) 195-202
19. Krasteva M., Peguet-Navarro J., Moulon C., Courtellemont P., Redziniak G., and Schmitt D. In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells-a screening predictive assay for contact sensitizers. Clin. Exp. Allergy 26 (1996) 563-570
20. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., and Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223 (1999) 77-92
21. Magnusson B., and Kligman A.M. The identification of contact allergens by animal assay. The guinea pig maximization test. J. Invest. Dermatol. 52 (1969) 268-276
22. Manome H., Aiba S., and Tagami H. Simple chemicals can induce maturation and apoptosis of dendritic cells. Immunology 98 (1999) 481-490
23. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
24. Olasz E.B., Linton J., and Katz S.I. Soluble proteins and haptens on bone marrow-derived dendritic cells are presented to host CD4 T cells in an MHC-restricted manner. Int. Immunol. 14 (2002) 493-502
25. Pichowski J.S., Cumberbatch M., Dearman R.J., Basketter D.A., and Kimber I. Investigation of induced changes in interleukin 1beta mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing. Toxicol. In Vitro 14 (2000) 351-360
26. Pichowski J.S., Cumberbatch M., Dearman R.J., Basketter D.A., and Kimber I. Allergen-induced changes in interleukin 1 beta (IL-1 beta) mRNA expression by human blood-derived dendritic cells: inter-individual differences and relevance for sensitization testing. J. Appl. Toxicol. 21 (2001) 115-121
27. Rizova H., Carayon P., Barbier A., Lacheretz F., Dubertret L., and Michel L. Contact allergens, but not irritants, alter receptor-mediated endocytosis by human epidermal Langerhans cells. Br. J. Dermatol. 140 (1999) 200-209
28. Rougier N., Redziniak G., Mougin D., Schmitt D., and Vincent C. In vitro evaluation of the sensitization potential of weak contact allergens using Langerhans-like dendritic cells and autologous T cells. Toxicology 145 (2000) 73-82
29. Ryan C.A., Gerberick G.F., Gildea L.A., Hulette B.C., Betts C.J., Cumberbatch M., Dearman R.J., and Kimber I. Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment. Toxicol. Sci. 88 (2005) 4-11
30. Sakaguchi H., Ashikaga T., Miyazawa M., Yoshida Y., Ito Y., Yoneyama K., Hirota M., Itagaki H., Toyoda H., and Suzuki H. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. Toxicol. In Vitro 20 (2006) 774-784
31. Schuurhuis D.H., Fu N., Ossendorp F., and Melief C.J. Ins and outs of dendritic cells. Int. Arch. Allergy Immunol. 140 (2006) 53-72
32. Staquet M.J., Sportouch M., Jacquet C., Schmitt D., Guesnet J., and Peguet-Navarro J. Moderate skin sensitizers can induce phenotypic changes on in vitro generated dendritic cells. Toxicol. In Vitro 18 (2004) 493-500
33. Straube F., Grenet O., Bruegger P., and Ulrich P. Contact allergens and irritants show discrete differences in the activation of human monocyte-derived dendritic cells: consequences for in vitro detection of contact allergens. Arch. Toxicol. 79 (2005) 37-46
34. Toebak M.J., Pohlmann P.R., Sampat-Sardjoepersad S.C., von Blomberg B.M., Bruynzeel D.P., Scheper R.J., Rustemeyer T., and Gibbs S. CXCL8 secretion by dendritic cells predicts contact allergens from irritants. Toxicol. In Vitro 20 (2006) 117-124
35. Tuschl H., and Kovac R. Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. Toxicol. In Vitro 15 (2001) 327-331
36. Tuschl H., Kovac R., and Weber E. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol. In Vitro 14 (2000) 541-549
37. Verheyen G.R., Schoeters E., Nuijten J.M., Van Den Heuvel R.L., Nelissen I., Witters H., Van Tendeloo V.F., Berneman Z.N., and Schoeters G.E. Cytokine transcript profiling in CD34+-progenitor derived dendritic cells exposed to contact allergens and irritants. Toxicol. Lett. 155 (2005) 187-194
38. Verrier A.C., Schmitt D., and Staquet M.J. Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells. Int. Arch. Allergy Immunol. 120 (1999) 56-62
39. Yoshida Y., Sakaguchi H., Ito Y., Okuda M., and Suzuki H. Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. Toxicol. In Vitro 17 (2003) 221-228